Common Contracts

ROYALTY PURCHASE AGREEMENT dated as of March 22, 2021 between VIRACTA THERAPEUTICS, INC., as Seller, and XOMA (US) LLC, as Purchaser

Royalty Purchase Agreement • May 13th, 2021 • Viracta Therapeutics, Inc. • Pharmaceutical preparations • Delaware

• Contract Type
  Royalty Purchase Agreement
• Filed
  May 13th, 2021
• Company
  Viracta Therapeutics, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

This ROYALTY PURCHASE AGREEMENT (this “Agreement”) dated as of March 22, 2021 (the “Effective Date”), is between VIRACTA THERAPEUTICS, INC., a corporation organized and existing under the laws of Delaware, with an office located at 2533 South Coast Highway 101, #210, Cardiff CA 92007 (“Seller”), and XOMA (US) LLC, a Delaware limited liability company with its principal place of business at 2200 Powell Street, Suite 310, Emeryville, California 94608 (“Purchaser”).

ROYALTY PURCHASE AGREEMENT

Royalty Purchase Agreement • May 6th, 2021 • XOMA Corp • Pharmaceutical preparations • Delaware

• Contract Type
  Royalty Purchase Agreement
• Filed
  May 6th, 2021
• Company
  XOMA Corp
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

[*] = Certain confidential information contained in this document, marked by brackets, has been omitted because it is both (i) not material and (ii) is the type that the registrant treats as private or confidential.